Skip to content

Jazz Pharmaceuticals JAZZ Dividends, Common Stock, Cash

Dividends, Common Stock, Cash at other companies

Reliance logo
RelianceRS
$66.6M+2.1%
Simon Property Group logo
Simon Property GroupSPG
$715.71M+4.3%
CMS
CMS EnergyCMS
$178M+7.2%
ATI logo
ATIATI
$3M
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DividendsCommonStockCash.

The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's dividends, common stock, cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's dividends, common stock, cash?
Jazz Pharmaceuticals (JAZZ) reported dividends, common stock, cash of $0 in Q4 2025.
What does dividends, common stock, cash mean?
Cash paid out to shareholders as dividends.
How do you interpret dividends, common stock, cash?
Consistent or growing dividends signal management confidence in cash flow stability, while a lack of dividends may indicate a focus on reinvestment.
How does dividends, common stock, cash compare across companies?
Commonly tracked by income-focused investors; biopharma companies often prioritize R&D over dividends.